Which of the following is not a myeloproliferative disease?
**Core Concept**
The myeloproliferative diseases (MPDs) are a group of clonal hematopoietic disorders characterized by the excessive production of mature blood cells, including red blood cells, white blood cells, and platelets. This results from the abnormal proliferation of hematopoietic stem cells, leading to increased cell counts in the bone marrow and peripheral blood.
**Why the Correct Answer is Right**
The correct answer is not one of the myeloproliferative diseases, which include:
* Essential thrombocytopenia (ET)
* Polycythemia vera (PV)
* Primary myelofibrosis (PMF)
* Chronic myeloid leukemia (CML)
These conditions are all characterized by the overproduction of mature blood cells, often due to mutations in genes such as JAK2, CALR, or MPL. In contrast, the correct answer does not exhibit this characteristic overproduction of blood cells.
**Why Each Wrong Option is Incorrect**
**Option B:** This option is incorrect because it is a type of myeloproliferative disease characterized by the overproduction of platelets. Essential thrombocytopenia (ET) is a classic example of a myeloproliferative disease.
**Option C:** This option is incorrect because it is a type of myeloproliferative disease characterized by the overproduction of red blood cells. Polycythemia vera (PV) is a classic example of a myeloproliferative disease.
**Option D:** This option is incorrect because it is a type of myeloproliferative disease characterized by the overproduction of white blood cells. Chronic myeloid leukemia (CML) is a classic example of a myeloproliferative disease.
**Clinical Pearl / High-Yield Fact**
The JAK2 V617F mutation is a common genetic abnormality found in many myeloproliferative diseases, including polycythemia vera, essential thrombocytopenia, and primary myelofibrosis. This mutation leads to the constitutive activation of the JAK/STAT signaling pathway, resulting in the overproduction of blood cells.
**Correct Answer: A.**